代谢相关脂肪性肝病的中医研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(82374308);国家重点研发计划项目(2022YFC2010104);中央级公益性科研院所基本科研业务费专项资金资助项目(YZ-202157);山西中医药大学博士科研启动基金资助项目(2024BK07)


Advances in Traditional Chinese Medicine Research on Metabolism-associated Fatty Liver Disease
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    中医药防治包括代谢相关脂肪性肝病(MAFLD)等的代谢性疾病效果显著。现从MAFLD的中医病名,病因病机,证候分型,体质辨识,中药汤药、中成药、非药物疗法等治疗手段,化痰祛瘀、养肝益肾、疏肝健脾、化湿清热等治则治法,中医动物模型、单味药及有效成分、复方等作用机制研究方面进行综述,以归纳总结中医药防治MAFLD的相关研究进展,为后续研究提供一定的借鉴和参考。

    Abstract:

    Traditional Chinese medicine(TCM) has demonstrated significant efficacy in the prevention and treatment of metabolic diseases,including metabolic-associated fatty liver disease(MAFLD).This review explores various aspects of TCM in the management of MAFLD,including its TCM nomenclature,etiology and pathogenesis,syndrome differentiation,and constitution classification.Additionally,it summarizes treatment approaches such as Chinese herbal decoctions,Chinese patent medicines,and non-pharmacological therapies.The therapeutic principles of resolving phlegm and removing stasis,nourishing the liver and kidney,soothing the liver and strengthening the spleen,and resolving dampness and clearing heat are discussed in detail.Furthermore,research progress in TCM-related MAFLD studies,including animal models,single herbs and active components,and compound formulas,is reviewed.This study aims to provide insights and references for future research on TCM-based MAFLD prevention and treatment.

    参考文献
    相似文献
    引证文献
引用本文

张潞潞,张建军,张秀平,方旖旎,董阳,王晓乾,张钧豪,张鹏,程引,王立英,李玲孺.代谢相关脂肪性肝病的中医研究进展[J].世界中医药,2025,(05).

复制
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2024-01-04
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2025-06-04
  • 出版日期:
文章二维码